Company intelligence / Profile preview
InnDura Therapeutics
Cambridge, Massachusetts, United Statesinndura.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
InnDura Therapeutics is a pre-clinical stage company developing EVE16-engineered Natural Killer (NK) cell therapies for cancer treatment. The EVE16 platform enables enhanced cancer cell killing with greatly reduced cellular exhaustion and fratricide.[1]
- Therapeutic areas
- Oncology
- Modalities
- NK cell therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Landmark Bio
Beyond the preview
Go deeper on InnDura Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InnDura Therapeutics.